Gene-Specific DNA Methylation Profiles in Pediatric Medulloblastomas

Area of Science:

• Oncology
• Genomics
• Molecular Biology

Background:

• Medulloblastoma is a highly malignant pediatric central nervous system tumor.
• Current classification includes histological and molecular subgroups, but genomic understanding and clinical course prediction require further investigation.
• DNA methylation profiles are increasingly recognized for their role in cancer subclassification and therapeutic strategies.

Purpose of the Study:

• To investigate the significance of DNA methylation profiles in the molecular subclassification of pediatric medulloblastoma.
• To explore the potential of methylation profiling for precision medicine approaches in medulloblastoma treatment.
• To correlate methylation patterns of specific genes with clinicopathological parameters.

Main Methods:

• Analysis of DNA methylation levels for genes including KLF4, SPINT2, RASSF1A, EZH2, ZIC2, and PTCH1 in 47 pediatric medulloblastoma patients.
• Utilized methylation-specific pyrosequencing for accurate DNA methylation analysis.
• Statistical analysis correlated methylation profiles with molecular subgroups, histological subtypes, metastatic status, and event-free survival.

Main Results:

• Hypermethylation of KLF4, PTCH1, and ZIC2 was significantly associated with the SHH-activated molecular subgroup.
• Hypermethylation of SPINT2 and RASSF1A correlated with the presence of metastatic disease.
• The EZH2 gene showed no methylation in any of the analyzed samples.

Conclusions:

• DNA methylation profiling demonstrates utility in refining the molecular subclassification of pediatric medulloblastoma.
• Customized methylation profiling presents a potential technical approach for advancing precision medicine in medulloblastoma.
• These findings support the integration of epigenetic markers into the diagnostic and therapeutic landscape of medulloblastoma.